Insider · CIK 0001696784

Duvall Diantha

Reports to the SEC for 3 companies · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001696784

Forms 4 and 5

Insider transactions

47 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-07	CRISCURIS INC · Employee stock option (right to buy)A Award	CFO	AAward	+48.3K sh	$5.29	+$255K	48,285
2026-03-20	CRISCURIS INCC Conversion	CFO	CConversion	+66.7K sh	—	—	77,707
2026-03-20	CRISCURIS INC · Series B Convertible Preferred StockC Conversion	CFO	CConversion	−50 sh	—	—	0
2026-03-17	CRISCURIS INC · Series B Convertible Preferred StockA Award	CFO	AAward	+50 sh	—	—	50
2026-03-17	CRISCURIS INC · Series A Warrant (right to buy)A Award	CFO	AAward	+66.7K sh	—	—	66,666
2026-03-17	CRISCURIS INC · Series B Warrant (right to buy)A Award	CFO	AAward	+66.7K sh	—	—	66,666
2026-03-17	CRISCURIS INC · Series C Warrant (right to buy)A Award	CFO	AAward	+66.7K sh	—	—	66,666
2025-05-20	CRISCURIS INC · Employee stock option (right to buy)A Award	CFO	AAward	+135K sh	$3.13	+$423K	135,000
2025-01-28	CRISCURIS INC · Employee stock option (right to buy)A Award	CFO	AAward	+15K sh	$3.13	+$47K	15,000
2024-05-21	CRISCURIS INC · Employee stock option (right to buy)A Award	CFO	AAward	+39K sh	$11.62	+$453K	39,000
2023-01-20	CRISCURIS INC · Employee stock option (right to buy)A Award	CFO	AAward	+500K sh	—	—	500,000
2022-06-02	GENOCEA BIOSCIENCES, INC.S Sale	CHIEF FINANCIAL OFFICER	SSale	−1,355 sh	$0.06	−$81.3	75,388
2022-05-26	GENOCEA BIOSCIENCES, INC.S Sale	CHIEF FINANCIAL OFFICER	SSale	−24.4K sh	$0.08	−$1,867.135	76,743
2022-04-04	GENOCEA BIOSCIENCES, INC.S Sale	CHIEF FINANCIAL OFFICER	SSale	−963 sh	$1.25	−$1,203.75	91,775
2022-03-16	GENOCEA BIOSCIENCES, INC.S Sale	CHIEF FINANCIAL OFFICER	SSale	−2,873 sh	$1.10	−$3,160.3	92,738
2022-03-15	GENOCEA BIOSCIENCES, INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+37.5K sh	—	—	95,611
2022-03-15	GENOCEA BIOSCIENCES, INC.Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+113K sh	—	—	112,500
2021-06-01	GENOCEA BIOSCIENCES, INC.S Sale	CHIEF FINANCIAL OFFICER	SSale	−511 sh	$2.23	−$1,139.53	62,486
2021-04-02	GENOCEA BIOSCIENCES, INC.S Sale	CHIEF FINANCIAL OFFICER	SSale	−925 sh	$2.71	−$2,506.75	62,997
2021-03-15	GENOCEA BIOSCIENCES, INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+37.5K sh	—	—	37,500
2021-03-15	GENOCEA BIOSCIENCES, INC.Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+113K sh	—	—	112,500
2021-03-15	GENOCEA BIOSCIENCES, INC.Restricted Stock UnitA Award	CHIEF FINANCIAL OFFICER	AAward	+100K sh	—	—	100,000
2020-06-01	GENOCEA BIOSCIENCES, INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+6,623 sh	—	—	6,623
2020-06-01	GENOCEA BIOSCIENCES, INC.Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+24.9K sh	—	—	24,938
2020-04-02	GENOCEA BIOSCIENCES, INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+12.3K sh	—	—	12,299
2020-04-02	GENOCEA BIOSCIENCES, INC.Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+46.3K sh	—	—	46,313
2019-03-05	GENOCEA BIOSCIENCES, INC.Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+475K sh	—	—	475,000
2018-03-08	Bioverativ Inc.D Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−2,791 sh	—	—	0
2018-03-08	Bioverativ Inc.Restricted Stock UnitsD Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−2,780 sh	—	—	0
2018-03-08	Bioverativ Inc.Restricted Stock UnitsD Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−7,273 sh	—	—	0
2018-03-08	Bioverativ Inc.Non-Qualified Stock OptionD Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−7,030 sh	—	—	0
2018-03-08	Bioverativ Inc.Non-Qualified Stock OptionD Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−11.1K sh	—	—	0
2018-03-02	Bioverativ Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−105 sh	$104.73	−$11K	2,791
2018-02-22	Bioverativ Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−168 sh	$104.30	−$17.5K	2,896
2018-02-14	Bioverativ Inc.M Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+1,390 sh	—	—	3,518
2018-02-14	Bioverativ Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−454 sh	$103.52	−$47K	3,064
2018-02-14	Bioverativ Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−1,390 sh	—	—	2,780
2018-01-31	Bioverativ Inc.Restricted Stock UnitsA Award	Chief Accounting Officer	AAward	+7,273 sh	—	—	7,273
2017-06-28	Bioverativ Inc.S Sale	Chief Accounting Officer	SSale	−818 sh	$60.47	−$49.5K	2,128
2017-05-02	Bioverativ Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−99 sh	$57.48	−$5,690.52	2,946
2017-03-02	Bioverativ Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−113 sh	$52.81	−$5,967.53	3,045
2017-02-28	Bioverativ Inc.A Award	Chief Accounting Officer	AAward	+3,360 sh	—	—	3,369
2017-02-28	Bioverativ Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−211 sh	$47.76	−$10.1K	3,158
2017-02-28	Bioverativ Inc.Non-Qualified Stock OptionA Award	Chief Accounting Officer	AAward	+7,030 sh	—	—	7,030
2017-02-14	Bioverativ Inc.Non-Qualified Stock OptionA Award	Chief Accounting Officer	AAward	+11.1K sh	—	—	11,062
2017-02-14	Bioverativ Inc.Restricted Stock UnitsA Award	Chief Accounting Officer	AAward	+4,170 sh	—	—	4,170
2017-02-14	Bioverativ Inc.Non-Qualified Stock OptionA Award	Chief Accounting Officer	AAward	+11K sh	—	—	11,043

Recent filings

Accepted (ET)
Jul 94
Duvall Diantha0001108205-26-000091
SEC(opens sec.gov)
Mar 234
Duvall Diantha0001108205-26-000038
SEC(opens sec.gov)
Mar 184
Duvall Diantha0001108205-26-000026
SEC(opens sec.gov)
May 224
Duvall Diantha0001108205-25-000065
SEC(opens sec.gov)
Jan 304
Duvall Diantha0001108205-25-000018
SEC(opens sec.gov)
May 234
Duvall Diantha0001108205-24-000055
SEC(opens sec.gov)
Jan 244
Duvall Diantha0001108205-23-000011
SEC(opens sec.gov)
Jun 34
Duvall Diantha0001457612-22-000075
SEC(opens sec.gov)
May 264
Duvall Diantha0001457612-22-000060
SEC(opens sec.gov)
Apr 54
Duvall Diantha0001457612-22-000045
SEC(opens sec.gov)
Mar 174
Duvall Diantha0001457612-22-000030
SEC(opens sec.gov)
Mar 165
Duvall Diantha0001457612-22-000020
SEC(opens sec.gov)
Mar 174
Duvall Diantha0001457612-21-000042
SEC(opens sec.gov)

Companies

Address

128 SPRING STREET BUILDING C - SUITE 500

LEXINGTON, MA, 02421